Coronavirus information from UCLA and UCLA Health


The Next Generation Incubator

Innovative Physics to Study Life. Commercializing First in Kind Live Cell Sequencing.

Charlot Biosciences, Inc. is creating an economical, multi-functional platform to help researchers accelerate the discovery of biomarkers to identify the presence of early-stage disease. Their BioDiscovery™ platform streamlines filtration, refinement, and quantification of biomarkers found in physiological samples. The process, Intrepid Microfluidics™, identifies biomarkers based on their inherent biophysical properties. This tunable and non-destructive approach enables identification of biomarkers with high fidelity and also enables reuse of the sample. Charlot’s technology platform provides helpful solutions for CRISPR/CAS9 gene editing, study of the microbiome, stem cell research, and much more.

Graduated in 2018
Location: Wayfinder Incubator in Irvine, CA

Phone: 858-255-1238